Smith Cynthia - Insider Non-Derivative Transactions at Spero Therapeutics, Inc. (SPRO) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on May 29, 2024, Smith Cynthia's relationship to Spero Therapeutics, Inc. (SPRO) is Director, and currently has 55,000 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other SPRO insiders.
Data Source: SEC.
Smith Cynthia - Insider Non-Derivative Transactions of SPRO Common Stock
Smith Cynthia - Insider Non-Derivative Transactions at SPRO
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| May 30, 2024 | Acquisition -- (Common Stock) | 20000 | 0 | 55000 |
| Oct 6, 2023 | Acquisition -- (Common Stock) | 20000 | 0 | 35000 |